Starton Therapeutics (Starton Therapeutics) Beginning Cash Position : $0.14 Mil (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Beginning Cash Position?

Starton Therapeutics's Beginning Cash Position for the quarter that ended in Jun. 2023 was $0.14 Mil.

Starton Therapeutics's quarterly Beginning Cash Position increased from Dec. 2022 ($0.00 Mil) to Mar. 2023 ($0.07 Mil) and increased from Mar. 2023 ($0.07 Mil) to Jun. 2023 ($0.14 Mil).

Starton Therapeutics's annual Beginning Cash Position declined from Mar. 2021 ($4.01 Mil) to Mar. 2022 ($3.69 Mil) and declined from Mar. 2022 ($3.69 Mil) to Mar. 2023 ($0.33 Mil).

Starton Therapeutics Beginning Cash Position Historical Data

The historical data trend for Starton Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Beginning Cash Position Chart

Starton Therapeutics Annual Data

Trend

Mar21

Mar22

Mar23

Beginning Cash Position

4.01

3.69

0.33

Starton Therapeutics Quarterly Data
	Mar21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23
Beginning Cash Position	Get a 7-Day Free Trial			0.83	0.33	-	0.07	0.14

Starton Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Starton Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Starton Therapeutics (Starton Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

215 College Road, Suite No.300, Paramus, NJ, USA, 07652

Website

https://www.startontx.com

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines